Hà Nội, a Metropolis in the Making: The Breakdown in Urban Integration of Villages von Sylvie Fanchette

Volltext

Hà Nội, a Metropolis in the Making von Boudreau, J.-A, Brouillac, Ph, Cerise, E, De Koninck, Rodolphe, Duchère, Y, Fanchette, S, Labbé, D, Mounier, C, Moustier, P, Musil, C, Nhật Kiên, Trần, Orfeuvre, R, Pandolfi, L, Segard, J, Thế Anh, Ðào, Thị Tân Lộc, Nguyễn, Văn Hùng, Lê, Văn Sửu, Nguyễn, Xuân Hoản, Nguyễn

Volltext

Chapter 1. Hà Nội between the ‘waters’ von Fanchette, S, Orfeuvre, R, Nhật Kiên, Trần

Volltext

Chapter 2. Hà Nội: the villages, the heart of social and patrimonial life von Orfeuvre, R, Brouillac, Ph, Mounier, C

Volltext

Addition of Epirubicin As a Third Drug to Carboplatin-Paclitaxel in First-Line Treatment of Advanced Ovarian Cancer: A Prospectively Randomized Gynecologic Cancer Intergroup Trial... von DU BOIS, Andreas, WEBER, Beatrice, RICHTER, Barbara, LUECK, Hans-Joachim, PFISTERER, Jacobus, COSTA, Serban, SCHROEDER, Willibald, KIMMIG, Rainer, PUJADE-LAURAINE, Eric, ROCHON, Justine, MEIER, Werner, GOUPIL, Alain, OLBRICHT, Sigrid, BARATS, Jean-Claude, KUHN, Walther, ORFEUVRE, Hubert, WAGNER, Uwe

Volltext

Randomised, open-label, multicentric phase III trial to evaluate the safety and efficacy of palbociclib in combination with endocrine therapy, guided by ESR1 mutation monitoring in... von Berger, Frédérique, Marce, Margaux, Hardy-Bessard, Anne-Claire, Bachelot, Thomas, Bièche, Ivan, Pradines, Anne, De La Motte Rouge, Thibault, Canon, Jean-Luc, André, Fabrice, Clatot, Florian, Lemonnier, Jérôme, Marques, Sandrine, Bidard, François-Clement, Achille, M, Alleaume, C, Ammarguellat, H, Arsene, O, Bachelot, T, Barthelemy, P, Barthier, S, Bernard-Marty, C, Bonichon-Lamichhane, N, Bonnin, N, Bouaita, R, Boudrant, A, Brunel, V-A, Chakiba, C, Cheneau, C, Clatot, F, Dalenc, F, De Gramont, A, de La Motte Rouge, T, Deiana, L, Del Piano, F, Delbaldo, C, Delecroix, V, Derbel, O, Desclos, H, D'Hondt, V, Dohollou, N, Dubot, C, Escande, A, Ferrero, J-M, Foa, C, Frenel, J-S, Gardner, M, Garnier Tixidre, C, Genet, D, Gisserot, O, Gozy, M, Greilsamer, C, Grenier, J, Guinet, F, Hardy-Bessard, A-C, Jacquin, J-P, Joly, L, Lachaier, E, Ladoire, S, Laurenty, A-P, Le Scodan, R, Leduc, N, Levache, C, Lorchel, F, Lortholary, A, Lucas, B, Marques, N, Marti, A, Melis, A, Mille, D, Mollon, D, Moreau, L, Moullet, I, Mouret-Reynier, M-A, Najem, A, Nguyen, S, Orfeuvre, H, Paitel, J-F, Petit, T, Pistilli, B, Plaza, J, Riedl, C, Sabatier, R, Soulie, P, Spaeth, D, Stefani, L, Teixeira, L, Trouboul, F, Valmar, C, Vegas, H, Venat-Bouvet, L, Zannetti, A, Bidard, FC, Delaloge, S, Bièche, I, Clatot, Florian, Canon, JL, André, F, Arnould, L, Berger, F, Marques, S

Volltext

Anterior cruciate ligament reconstruction with the Tape Locking Screw (TLS) and a short hamstring graft: Clinical evaluation of 61 cases with a minimum 12 months’ follow-up von Orfeuvre, Benoît, Pailhé, Régis, Sigwalt, Loïc, Rubens Duval, Brice, Lateur, Gabriel, Plaweski, Stéphane, Saragaglia, Dominique

Volltext

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial von Kerbrat, Pierre, Fumoleau, Pierre, Jacquin, Jean-Philippe, Abadie-Lacourtoisie, Sophie, Cany, Laurent, Khayat, David, Paget-Bailly, Sophie, Demarchi, F, N'Guyen, T, Stein, U, Villanueva, C, Guimont, I, Lévy, E, Delbaldo, C, Pouessel, D, Fournel-Fédérico, C, Freyer, G, Tartas, S, Bons, F, Cuvier, C, Hajjaji, N, Capitain, O, Maillart, P, Bonnefoi, H, Durand, M, Madranges, N, Mauriac, L, Durando, X, Durieux, A, Piperno-Neumann, S, Tresca, P, Ferrant, E, Mayer, F, Vanneuville, AC, Servent, V, Guastalla, JP, Biron, P, Dupuy-Brousseau, L, Lancry, L, Trédan, O, Extra, JM, Berton-Rigaud, D, Ferrero, JM, Largillier, R, Gedoin, D, Laguerre, B, Lefeuvre, C, Vauléon, E, Tennevet, I, Mefti-Lacheraf, F, Dalenc, F, André, F, Domont, J, Ezenfis, J, Provençal, J, Bellaiche-Miccio, C, Boutan-Laroze, G, Arsène, O, Merad-Boudia, Z, Orfeuvre, H, Lamy, R, Sarda, C, Salles, B, Cauvin, I, Mangold, M, Bourcier, A, Geay, JF, ElAmarti, R, Combe, M, Dauba, J, Denizon, N, Clavreul, G, Goubely, Y, Delecroix, V, Ligeza-Poisson, V, Leyronnas, C, Teissier, E, Bernard, O, Pottier-Kyndt, V, Drony, S, Moriceau, M, Besson, D, Achille, E, Moran-Ribon, A, Moullet, I, Couderc, B, Burki, F, Schaeffer, F, Montcuquet, P, Baumont, GA, Gréget, S, Ratoanina, JL, Bonichon-Lamichhane, M, Cartron, G, Dupuis, O, Ganem, G, LeRol, A, Antoine, EC, Llory, JF, Loiseau, D

Volltext

Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial von Peyrade, Frédéric, Dr, Jardin, Fabrice, Prof, Thieblemont, Catherine, Prof, Thyss, Antoine, Prof, Emile, Jean-François, Prof, Castaigne, Sylvie, Prof, Coiffier, Bertrand, Prof, Haioun, Corinne, Prof, Bologna, Serge, MD, Fitoussi, Olivier, MD, Lepeu, Gérard, MD, Fruchart, Christophe, MD, Bordessoule, Dominique, MD, Blanc, Michel, MD, Delarue, Richard, Prof, Janvier, Maud, MD, Salles, Bruno, MD, André, Marc, MD, Fournier, Marion, Gaulard, Philippe, Prof, Tilly, Hervé, Prof

Volltext

Intensified chemotherapy with ACVBP plus rituximab versus standard CHOP plus rituximab for the treatment of diffuse large B-cell lymphoma (LNH03-2B): an open-label randomised phase... von Récher, Christian, Prof, Coiffier, Bertrand, Prof, Haioun, Corinne, Prof, Molina, Thierry Jo, Prof, Fermé, Christophe, MD, Casasnovas, Olivier, MD, Thiéblemont, Catherine, Prof, Bosly, André, Prof, Laurent, Guy, Prof, Morschhauser, Franck, MD, Ghesquières, Hervé, MD, Jardin, Fabrice, Prof, Bologna, Serge, MD, Fruchart, Christophe, MD, Corront, Bernadette, MD, Gabarre, Jean, MD, Bonnet, Christophe, MD, Janvier, Maud, MD, Canioni, Danielle, Prof, Jais, Jean-Philippe, MD, Salles, Gilles, Prof, Tilly, Hervé, Dr, Prof

Volltext

Multicentre, phase II study evaluating capecitabine monotherapy in patients with anthracycline- and taxane-pretreated metastatic breast cancer von Fumoleau, P., Largillier, R., Clippe, C., Dièras, V., Orfeuvre, H., Lesimple, T., Culine, S., Audhuy, B., Serin, D., Curé, H., Vuillemin, E., Morère, J.-F., Montestruc, F., Mouri, Z., Namer, M.

Volltext

ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III–IV low-risk Hodgkin lymphoma (IPS 0–2) of the LYSA H34 randomized trial von Mounier, N., Brice, P., Bologna, S., Briere, J., Gaillard, I., Heczko, M., Gabarre, J., Casasnovas, O., Jaubert, J., Colin, P., Delmer, A., Devidas, A., Bachy, E., Nicolas-Virelizier, E., Aoudjhane, A., Humbrecht, C., Andre, M., Carde, P.

Volltext

Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer von von Minckwitz, Gunter, Huang, Chiun-Sheng, Mano, Max S, Loibl, Sibylle, Mamounas, Eleftherios P, Untch, Michael, Wolmark, Norman, Rastogi, Priya, Schneeweiss, Andreas, Redondo, Andres, Fischer, Hans H, Jacot, William, Conlin, Alison K, Arce-Salinas, Claudia, Wapnir, Irene L, Jackisch, Christian, DiGiovanna, Michael P, Fasching, Peter A, Crown, John P, Wülfing, Pia, Shao, Zhimin, Rota Caremoli, Elena, Wu, Haiyan, Lam, Lisa H, Tesarowski, David, Smitt, Melanie, Douthwaite, Hannah, Singel, Stina M, Geyer, Charles E

Volltext

167MO Association between ER, PR and HER2 levels and outcome under palbociclib (Pal) + aromatase inhibitors (AIs) as first-line therapy for ER+ HER2- metastatic breast cancer (MBC)... von De La Motte Rouge, T., Frenel, J-S., Hardy-Bessard, A-C., Bachelot, T., Pistilli, B., Delaloge, S., Deiana, L., Del Piano, F., Genet, D., Gardner, M., Legouffe, E., Levache, C.B., Orfeuvre, H., Valmar, C., Venat, L., Zannetti, A., Le Scodan, R., Dalenc, F., Berger, D., Bidard, F.C.

Volltext

Independent clinical appraisal of the Tape Locking Screw (TLS®) anterior cruciate ligament reconstruction technique compared with the hamstring graft technique with a minimum of 12... von Orfeuvre, B., Pailhé, R., Sharma, A., Gaillot, J., Rubens Duval, B., Saragaglia, D.

Volltext

Identification of a leukemic counterpart of the plasmacytoid dendritic cells von Chaperot, Laurence, Bendriss, Nathalie, Manches, Olivier, Gressin, Rémy, Maynadie, Marc, Trimoreau, Franck, Orfeuvre, Hubert, Corront, Bernadette, Feuillard, Jean, Sotto, Jean-Jacques, Bensa, Jean-Claude, Brière, Francine, Plumas, Joël, Jacob, Marie-Christine

Volltext

ACVBP versus CHOP plus Radiotherapy for Localized Aggressive Lymphoma von Reyes, Félix, Lepage, Eric, Ganem, Gérard, Molina, Thierry J, Brice, Pauline, Coiffier, Bertrand, Morel, Pierre, Ferme, Christophe, Bosly, Andre, Lederlin, Pierre, Laurent, Guy, Tilly, Hervé

Volltext

Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO von Berton-Rigaud, D., Selle, F., Floquet, A., Mollon, D., Lescaut, W., Kaminsky, M.-C., Ray-Coquard, I.L., Largillier, R., Savoye, A.-M., Barletta, H., Pautier, P., Orfeuvre, H., Baron, M., Marti, A., Mouysset, J.-L., Paoli, J.-B., Cailleux, P.-E., Cornea, C., Pujade-Lauraine, E.

Volltext

Docetaxel and pegylated liposomal doxorubicin combination as first-line therapy for metastatic breast cancer patients: results of the phase II GINECO trial CAPYTTOLE von de la Fouchardière, C., Largillier, R., Goubely, Y., Hardy-Bessard, A.-C., Slama, B., Cretin, J., Orfeuvre, H., Paraiso, D., Bachelot, T., Pujade-Lauraine, E.

Volltext

Dexamethasone-based regimens versus melphalan-prednisone for elderly multiple myeloma patients ineligible for high-dose therapy von Facon, Thierry, Mary, Jean-Yves, Pégourie, Brigitte, Attal, Michel, Renaud, Marc, Sadoun, Alain, Voillat, Laurent, Dorvaux, Véronique, Hulin, Cyrille, Lepeu, Gérard, Harousseau, Jean-Luc, Eschard, Jean-Paul, Ferrant, Augustin, Blanc, Michel, Maloisel, Frédéric, Orfeuvre, Hubert, Rossi, Jean-François, Azaïs, Isabelle, Monconduit, Mathieu, Collet, Philippe, Anglaret, Bruno, Yakoub-Agha, Ibrahim, Wetterwald, Marc, Eghbali, Houchingue, Vekemans, Marie-Christine, Maisonneuve, Hervé, Troncy, Jacques, Grosbois, Bernard, Doyen, Chantal, Thyss, Antoine, Jaubert, Jérome, Casassus, Philippe, Thielemans, Béatrice, Bataille, Régis

Volltext